SEARCH HEALTH CONDITIONS BY ALPHABETS
Familial Cold Autoinflammatory Syndrome
Medications for Familial Cold Autoinflammatory Syndrome
Other titles: Familial Cold Urticaria
About Familial Cold Autoinflammatory Syndrome: Familial Cold Autoinflammatory Syndrome is really where urticaria, joint swelling and pain, chills, and fever develop after exposure to chilly
Drugs Used to Treat Familial Cold Autoinflammatory Syndrome
This set of medications are used at the treatment of this condition, or somehow associated with.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Arcalyst | Rx | C | N | Two testimonials | 10 | ||
Generic title: rilonacept systemic Medicine course: interleukin inhibitors For consumers: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Ilaris | Rx | C | N | 1 inspection | 10 | ||
Generic title: canakinumab systemic Medicine course: interleukin inhibitors For consumers: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| canakinumab | Rx | C | N | 1 inspection | 10 | ||
Generic title: canakinumab systemic Brand title: Ilaris Medicine course: interleukin inhibitors For consumers: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph | |||||||
| rilonacept | Rx | C | N | Two testimonials | 10 | ||
Generic title: rilonacept systemic Brand title: Arcalyst Medicine course: interleukin inhibitors For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Off Label | This drug might not be approved by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have shown a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in elderly women clearly outweigh potential gains. |
| N | FDA have not classified the medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| 1 | Has a high potential for misuse. Has no accepted medical use in treatment in the USA. There`s just a lack of accepted safety for use under medical supervision. |
| Two | Has a high potential for misuse. Includes a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may lead to acute physical or psychological dependence. |
| 3 | features a potential for abuse less than individuals in programs 1 and 2. Includes a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse in accordance with individuals in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | Has a very low potential for abuse in accordance with individuals in program 4. Includes a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 4. |
| Alcohol | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult your physician to ensure the information displayed on this page relates to a personal circumstances.
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Top USA Pharma Companies
Popular Categories
Health Condition
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Easily find an affordable health insurance plan
